Home › Funds › BOSTON RESEARCH & MANAGEMENT INC › ALBPRA
BOSTON RESEARCH & MANAGEMENT INC position in ALBPRA
ALBEMARLE CORP
BOSTON RESEARCH & MANAGEMENT INC reported holding 99,720 shares of ALBPRA (ALBEMARLE CORP) in its Q3 2026 13F filing — a position valued at US$4.6M, representing 1.00% of its reported portfolio and ranking #44 among its reported holdings. BOSTON RESEARCH & MANAGEMENT INC has disclosed ALBPRA holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How BOSTON RESEARCH & MANAGEMENT INC's ALBPRA position evolved
BOSTON RESEARCH & MANAGEMENT INC first disclosed a stake in ALBPRA in Q3 2024 at 103,120 shares (US$4.6M). The position peaked in Q1 2026 at 100,820 shares, worth US$7.2M. Across 9 filings, BOSTON RESEARCH & MANAGEMENT INC increased the stake 2 time(s), trimmed it 4 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 99,720 shares valued at US$4.6M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 103.12K | $4.64M | New |
| Q4 2024 | 103.32K | $4.20M | Hold |
| Q1 2025 | 108.44K | $3.87M | Add |
| Q2 2025 | 121.96K | $3.91M | Add |
| Q3 2025 | 108.42K | $4.11M | Reduce |
| Q4 2025 | 104.02K | $6.18M | Reduce |
| Q1 2026 | 100.82K | $7.24M | Reduce |
| Q2 2026 | 99.82K | $5.53M | Reduce |
| Q3 2026 | 99.72K | $4.55M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ALBPRA and 13F data
ALBPRA (ALBEMARLE CORP) is a company whose sector is not yet classified in our data. 34 other funds we track also report a position in ALBPRA — the largest reported positions include Weiss Asset Management LP (US$105.9M), Aequim Alternative Investments LP (US$105.0M), Sculptor Capital LP (US$92.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ALBPRA
- Weiss Asset Management LP 1.91M sh · $105.86M · Q2 2026
- Aequim Alternative Investments LP 2.30M sh · $104.97M · Q3 2026
- Sculptor Capital LP 1.67M sh · $92.49M · Q2 2026
- WOLVERINE ASSET MANAGEMENT LLC 1.85M sh · $83.84M · Q3 2026
- CREDIT INDUSTRIEL ET COMMERCIAL 950.00K sh · $43.29M · Q3 2026
- SUSQUEHANNA ADVISORS GROUP, INC. 600.00K sh · $33.21M · Q2 2026
- Magnetar Financial LLC 657.27K sh · $29.98M · Q3 2026
- INFRASTRUCTURE CAPITAL ADVISORS, LLC 525.69K sh · $29.10M · Q2 2026
- CSS LLC/IL 470.58K sh · $26.08M · Q2 2026
More on BOSTON RESEARCH & MANAGEMENT INC
FAQ
How long has BOSTON RESEARCH & MANAGEMENT INC held ALBPRA?
BOSTON RESEARCH & MANAGEMENT INC has disclosed ALBPRA holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
What is BOSTON RESEARCH & MANAGEMENT INC's current position in ALBPRA?
As of Q3 2026, BOSTON RESEARCH & MANAGEMENT INC holds 99.72K shares of ALBPRA (ALBEMARLE CORP), valued at $4.55M, representing 1.00% of its reported portfolio and ranking #44.
Has BOSTON RESEARCH & MANAGEMENT INC been buying or selling ALBPRA?
In the latest 13F filing (Q3 2026), BOSTON RESEARCH & MANAGEMENT INC held unchanged its position in ALBPRA. The position peaked in Q1 2026 at 100.82K shares.
Which other funds hold ALBPRA?
Other major institutional holders of ALBPRA include Weiss Asset Management LP, Aequim Alternative Investments LP, Sculptor Capital LP, among 34 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.